A collaborative project backed by the National Cancer Institute, the cancer Biomedical Informatics Grid (caBIG) is serving as an umpire and scorekeeper of medical imaging research by setting the rules for assuring the validity of multicenter research and formatting results for easy tabulation and sharing.
A collaborative project backed by the National Cancer Institute, the cancer Biomedical Informatics Grid (caBIG) is serving as an umpire and scorekeeper of medical imaging research by setting the rules for assuring the validity of multicenter research and formatting results for easy tabulation and sharing.
The work of caBIG addresses current imaging research, with its need to test large populations at multiple sites. For future imaging practice, it is designed to satisfy a growing demand for standardized reporting and quality and effectiveness assessments.
At the 2009 RSNA meeting, members of the caBIG community will present examples of imaging capabilities in use that enable researchers to access data for their research and offer tools to optimize and validate imaging technologies. caBIG receives support from the National Cancer Institute and the Center for Biomedical Informatics and Information Technology.
Many community-based radiologists remain unaware of the role caBIG plays on the research front for promising applications. These include the use of imaging as a biomarker in clinical trials. They could potentially reduce the cost and time of drug development. Such trials typically include multiple sites and varied imaging equipment and practices. To make this possible, researchers must be able to view images and record image interpretation data in a standardized way, according to caBIG officials.
Additionally, caBIG is aiming at opportunities to advance meaningful scientific discovery and personalized medicine by integrating imaging data with other types of information, such as genomic or clinical outcomes data.
The caBIG educational exhibit (LL-ED-1007) and associated events will provide a visible presence for the grid at this event. It is debuting a new case study featuring commercial and academic perspectives on opportunities in medical imaging. Visitors to the exhibit can also experience some of the imaging tools firsthand through interactive demonstrations.
AI Facilitates Nearly 83 Percent Improvement in Turnaround Time for Fracture X-Rays
December 19th 2023In addition to offering a 98.5 percent sensitivity rate in diagnosing fractures on X-ray, an emerging artificial intelligence (AI) software reportedly helped reduce mean turnaround time on X-ray fracture diagnosis from 48 hours to 8.3 hours, according to new research presented at the Radiological Society of North America (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can an Emerging PET Radiotracer Enhance Detection of Prostate Cancer Recurrence?
December 14th 2023The use of 68Ga-RM2 PET/MRI demonstrated a 35 percent higher sensitivity rate than MRI alone for the diagnosis of biochemical recurrence of prostate cancer, according to research recently presented at the Radiological Society of North America (RSNA) conference.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
Can AI Improve Detection of Extraprostatic Extension on MRI?
December 4th 2023Utilizing a deep learning-based AI algorithm to differentiate between diagnostic and non-diagnostic quality of prostate MRI facilitated a 10 percent higher specificity rate for diagnosing extraprostatic extension on multiparametric MRI, according to research presented at the recent RSNA conference.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.